A two-shell arrangement strategy was successfully applied to the azaadamantane scaffold. With this strategy, seven nitro groups were introduced and the target product 2,9,9,10,10-pentanitro-2-azaadamantane-4,8-diyl dinitrate and its derivative 2-nitro-2-azaadamantane-4,8,9,10-tetrayl tetranitrate were prepared. The former exhibits a high density (1.878 g cm−3), together with an excellent detonation velocity (8914 m s−1) and pressure (36.16 GPa). More importantly, this strategy provides a new route to polynitroazaadamantanes with more than six nitro groups.
Despite the therapeutic benefits of insulin-pramlintide dual-hormone therapy in diabetes, its application potential has been limited due to a lack of efficient delivery routes. Here, we developed a temperature-responsive dual-hormone foam nanoengine (HormFoam) and combined it with a customized spraying device to further construct an in situ foam-generating system for improving the rectal bioavailability of dual-hormone therapy. To support rapid clinical translation, a continuous microfluidic preparation for HormFoam was proposed, including the power unit of perfluorocarbon nanodroplets and the pharmaceutical components Pluronic F127–functionalized liposomal insulin and pramlintide. We found that HormFoam could consistently generate foams to drive drugs forward after rectal administration, which enhanced intestinal distribution and mucosa absorption, leading to systemic codelivery of insulin-pramlintide. HormFoam reproduced the physiology of endocrine pancreas for glycemic control and induced body weight loss while reversing metabolic disorders in diabetic mice with good biosafety. Therefore, HormFoam represents a state-of-the-art dual-hormone regimen with the potential to address unmet needs in diabetes management.
Organic cage-like 3D frameworks can serve as crucial skeletal structures for the development of prospective energetic materials owing to their high inherent density, symmetrical structure, and flexible design. Herein, we present an efficient synthesis method for all-bridge carbon-substituted polynitroheteroadamantanes and their structural isomers for the first time. A series of novel energetic compounds (1–5) containing five or six explosophoric groups with four distinct frameworks (adamantane, proadamantane, homonoradamantane and twistane) was synthesized. All the five compounds exhibited high density (ρ > 1.85 g cm−3) and excellent detonation performance (D > 8500 m s−1, P > 34 GPa). In addition, they all possessed reasonable oxygen balance (OBco > 10%), which was superior to that of the classical highly explosive RDX (OBco = 0%). Furthermore, constructing the cage-like frameworks within two synthetic steps represented a significant advancement in the synthesis of cage-like compounds. This efficient synthetic method followed a concise route, exhibited time efficiency and possessed excellent molecule diversity of the raw material. These unique properties showed that cage-like frameworks have potential applications as high energy density materials.
Two series of energetic stereoisomers were synthesized via peripheral editing strategy. The differences in density and detonation performance indicate that stereochemistry holds promise as an effective strategy for designing and synthesizing HEDMs.
Four 2,6,9,13-functionalized pentacene derivatives were synthesized and used for sonodynamic therapy. In vitro and in vivo therapeutic results showed that these compounds could with ultrasound eliminate cancer cells.